Patents
Patents for C07D 513 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or (15,120)
08/2010
08/12/2010US20100204288 Heteroaryl-Ureas and Their Use as Glucokinase Activators
08/12/2010US20100204268 Processes for preparing different forms of (s)-(+)-clopidogrel bisulfate
08/12/2010US20100203007 Novel benzodiazepine derivatives
08/12/2010CA2750935A1 Heteroaryls and their use as pi3k inhibitors
08/11/2010CN101801982A Macrocyclic indole derivatives for the treatment of hepatitis C infections
08/11/2010CN101801981A Sirtuin modulating thiazolopyridine compounds
08/11/2010CN101798317A N-substituted aminothiazole morphinan compound and preparation method and applications thereof
08/11/2010CN101798316A Triazolothiadiazole compounds and preparation method and application thereof
08/10/2010US7772261 Pyrazolo[4,3-d]thiazole derivatives, and preparation and therapeutic application thereof
08/10/2010US7772260 Neuroprotectants; reduce side effect of neurotoxic agent; treatment of neuropathies resulting from chemotherapeutic agents used in the treatment of HIV and proliferative disease such as cancer and treatment of inflammatory diseases, neurodegenerative diseases
08/10/2010US7772229 Oxabispidine compounds useful in the treatment of cardiac arrhythmias
08/10/2010US7772198 cycstic fibrosis transmembrane conductance regulators (CFTR); for treatment of cystic fibrosis, asthma or diarrhea
08/10/2010CA2451605C Diamine derivatives
08/05/2010WO2010086481A1 New family of antichagasics derived from imidazo[4,5-c][1,2,6]thiadiazine 2,2-dioxide
08/05/2010US20100197910 Process for preparation of prulifloxacin using novel intermediates
08/04/2010CN101796056A heterocyclic inhibitors of c-met and uses thereof
08/03/2010US7767824 5,5-dibenzylimidazo[2,1-b]thiazol-6(5H)-one, useful as cognition activators in connection with treatments on memory disturbance, memory acquirement and retention disturbance, for example in Alzheimer's disease
08/03/2010US7767706 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication
08/03/2010US7767670 Substituted 3-carboxamido isoxazoles as kinase modulators
08/03/2010US7767659 Synthesis of naturally occurring ecteinascidins and related compounds
07/2010
07/29/2010WO2010085570A1 Poly (ADP-Ribose) Polymerase (PARP) Inhibitors
07/29/2010WO2010084508A2 Process for the preparation of type i, type ii and type iii crystalline prulifloxacin
07/29/2010WO2010014930A3 Piperidine derivatives as jak3 inhibitors
07/29/2010WO2010004457A3 Process for the preparation of 3, 4-dihydro-2h-thien [3, 2-e] -1, 2-thiazin-4-ol 1, 1 -dioxide derivatives and intermediates
07/29/2010US20100190774 Inhibitors of c-met and uses thereof
07/29/2010CA2750777A1 Bicyclic heterocyclic spiro compounds
07/29/2010CA2750106A1 Poly (adp-ribose) polymerase (parp) inhibitors
07/28/2010CN101790527A benzothiophene inhibitors of rho kinase
07/28/2010CN101790515A trans-3-aza-bicyclo[3.1.0]hexane derivatives
07/27/2010US7763729 Bicyclic heteroaromatic derivatives
07/27/2010US7763641 such as [(1S,2R)-2-hydroxy-3-[N-[4-(2-methylaminothiazol-4-yl)phenylsulfonyl]-N-(2-methylpropyl)amino]-1-(phenylmethyl)propyl]carbamic acid, [(3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl]ester, used for treating human immunodeficiency virus infections
07/27/2010US7763615 derivatives of ecteinascidins, particularly ecteinascidin 736, used for the treatment of lung, colon, kidney, prostate, cervical, ovarian, breast or pancreatic cancer, leukaemia or melanoma in mammals; reduced systemic toxicity and improved pharmacokinetics
07/22/2010WO2010083141A1 Bicyclic compounds for the reduction of beta-amyloid production
07/22/2010WO2010082612A1 Imidazothiazole derivative having proline ring structure
07/22/2010WO2010082531A1 Active blood coagulation factor inhibitor
07/22/2010WO2010082050A1 Macrocyclic and 7-aminoalkyl-substituted benzoxazocines for treatment of hepatitis c infections
07/22/2010WO2010062038A3 Tyrosine kinase inhibitor compound, isomer thereof or pharmaceutically allowable salt thereof, and pharmaceutical composition containing the same
07/22/2010US20100184808 3-aza-bicyclo[3.3.0]octane compounds
07/22/2010US20100184794 Fused heterocyclic compound
07/22/2010US20100184772 Sulfonamide substituted pyrazoline compounds, their preparation and use as cb1 modulators
07/22/2010US20100184751 Heterocyclic compounds for the treatment of tuberculosis
07/22/2010US20100183600 RAF Inhibitors and Their Uses
07/22/2010CA2750009A1 Imidazothiazole derivatives having proline ring structure
07/21/2010EP2207781A1 Thiazolopyrimidine p13k inhibitor compounds and methods of use
07/21/2010EP2207774A1 Triazole derivatives as scd inhibitors
07/21/2010EP1973920B1 Process for the preparation of 5-amino-3h-thiazolo [4,5-d] pyrimidin-2-one
07/21/2010EP1399445B9 Substituted pyrroloquinolines and pyridoquinolines as serotonin agonists and antagonists
07/21/2010CN101781321A Method for synthesizing Largazole and analog thereof
07/20/2010US7759372 benzimidazole derivatives having antiviral activities, used optionally in combination with a polymerase inhibitor and/or a protease inhibitor
07/20/2010US7759340 Antibacterial agents
07/15/2010WO2010079238A1 Heterotricyclic compounds as positive allosteric modulators of metabotropic glutamate receptors
07/15/2010US20100179190 Bicyclic pyrazolo protein kinase modulators
07/15/2010US20100179141 Novel jnk inhibitors
07/15/2010US20100179135 3-amino-6-(1-amino-ethyl)-tetrahydropyran derivatives
07/15/2010CA2748843A1 Heterotricyclic compounds as positive allosteric modulators of metabotropic glutamate receptors
07/14/2010EP2206715A1 Fused heterotetracyclic compounds and use thereof as hcv polymerase inhibitor
07/14/2010EP1863812B1 Dipeptidyl peptidase-iv inhibiting compounds, methods of preparing the same, and pharmaceutical compositions containing the same as an active agent
07/14/2010CN101778846A 1,2-diamido-ethylene derivatives as orexin antagonists
07/13/2010US7754743 Heteroarylcarbamoylbenzene derivatives
07/13/2010US7754719 Substituted piperidine derivatives as somatostatin SST1 receptor antagonists
07/13/2010CA2567776C Vasopressin v1a antagonists
07/13/2010CA2444611C Novel insecticidal azoles
07/13/2010CA2409697C Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
07/08/2010WO2010078408A1 Heteroaryl compounds useful as raf kinase inhibitors
07/08/2010WO2010077852A2 Method of inducing cleavage of amyloid precursor protein to form a novel fragment
07/08/2010WO2010077663A2 Substituted tetracyclic 1h-indeno (1,2-b) pyridine-2 (5h)-one analogs thereof and uses thereof
07/08/2010WO2010076525A1 Derivatives of 2-pyridin-2-yl-pyrazol-3(2h)-one, preparation and therapeutic use thereof
07/08/2010US20100173917 Urea derivatives as abl modulators
07/08/2010US20100173778 3-Biphenyl-substituted-3-substituted-4-ketolactam and ketolactone and their utilization as pesticide
07/08/2010US20100172960 Pro-drugs of nsaias with very high skin and membranes penetration rates and their new medicinal uses
07/08/2010CA2748413A1 Derivatives of 2-pyridin-2-yl-pyrazol-3(2h)-one, preparation and therapeutic use thereof
07/08/2010CA2748274A1 Heteroaryl compounds useful as raf kinase inhibitors
07/07/2010EP2203448A1 Phenothiazine derivative having a double bond, method for the production thereof, and use thereof as a pharmaceutical
07/07/2010EP2203424A1 Indole compounds bearing aryl or heteroaryl groups having sphingosine-1-phosphate (s1p) receptor biological activity
07/07/2010CN101772506A macrocycles and their uses
07/07/2010CN101768172A Optical active compound of anti-infective prulifloxacin and preparation method thereof
07/06/2010US7750160 inhibit p38, MAP kinase interacting serine/threonine kinase 2 (MKNK2 kinase) and serine-threonine kinases (STKs); treating proliferative diseases including cancer, leukemias; e.g. N-(isoxazolyl)urea compounds and thiourea compounds
07/06/2010US7750034 Aminocyclohexanes as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes
07/06/2010US7750021 3-{[2-(2-Trifluoromethyl-biphenyl-4-yl)-benzo[b]thiophen-5-ylmethyl]-amino}-propionic acid, useful in the treatment or prevention diseases associated with endothelial differentiation, G-protein-coupled (EDG) receptor mediated signal transduction, such as acute or chronic transplant rejection
07/06/2010US7750020 3-Cyclopentyl-2-(4-cyclopropylsulfamoyl-phenyl)-N-(5-methoxy-thiazolo[5,4-b]pyridin-2-yl)-propionamide; antidiabetic agent; insulin resistance, impaired glucose tolerance, obesity; with other hypolipidemic agent, anti-obesity and hypotensive agent
07/01/2010WO2010075204A2 Gamma secretase modulators
07/01/2010WO2010054024A3 1, 2 -thiazol yl derivatives as cannabinoid receptor ligands
07/01/2010US20100168418 Novel nitrogenated heterocyclic compound and salt thereof
07/01/2010US20100168101 Oxindole hydrazide modulators of protein tyrosine phosphatases (ptps)
07/01/2010US20100163813 Long wavelength shifted benzotriazole uv-absorbers and their use
07/01/2010CA2747750A1 Gamma secretase modulators
06/2010
06/30/2010EP2202222A2 Indene derivatives, their preparation and use as medicaments
06/30/2010EP2201019A1 Process for the preparation of 6-substituted-imidazo ý2,1-b¨thiazole-5-sulfonyl halide
06/30/2010EP2201018A2 Solid forms comprising n-(5-tert-butyl-isoxazol-3-yl)-n'-{4-ý7-(2-morpholin-4-yl-ethoxy)imidazoý2,1-b¨ý1,3¨benzothiazol-2-yl¨phenyl}urea, compositions thereof, and uses therewith
06/30/2010EP2200440A1 Antibacterial amide and sulfonamide substituted heterocyclic urea compounds
06/30/2010CN101765594A 1, 3-thiazol-2 (3H) -ylidene compounds as cannabinoid receptor ligands
06/30/2010CN101765593A 2-iminoisothiazole derivatives as cannabinoid receptor ligands
06/29/2010US7745449 Thieno-[2,3-d]pyrimidine and thieno-pyridazine compounds and methods of use
06/24/2010WO2010071853A1 Thiazolopyridine sirtuin modulating compounds
06/24/2010WO2010071822A1 Piperidine and piperazine derivatives and methods of use thereof
06/24/2010WO2010071819A1 Bicyclic heterocyclic derivatives and methods of use thereof
06/24/2010WO2010071783A1 Thiazoles as cannabinoid receptor ligands
06/24/2010WO2010071164A1 Activated blood coagulation factor x (fxa) inhibitor
06/24/2010WO2010071121A1 Method for producing diamine derivative
06/24/2010WO2010070452A1 Fused imidazole carboxamides as trpv3 modulators
1 ... 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 ... 152